Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alberto B. Alonso"'
Autor:
Richard A. Preston, David Afshartous, Evelyn V. Caizapanta, Barry J. Materson, Rolando Rodco, Eileen Alonso, Alberto B. Alonso
Publikováno v:
Hypertension. 79:813-826
Background: Potassium-induced natriuresis may contribute to the beneficial effects of potassium on blood pressure but has not been well-characterized in human postmenopausal hypertension. We determined the time course and magnitude of potassium-induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14927179183a97a1e2e09fc8fc2792d6
https://doi.org/10.1161/hypertensionaha.121.18392
https://doi.org/10.1161/hypertensionaha.121.18392
Autor:
Evelyn V. Caizapanta, David Afshartous, Rolando Rodco, Eileen Alonso, Richard A. Preston, Alberto B. Alonso, Barry J. Materson
Publikováno v:
Hypertension. 77:447-460
The thiazide-sensitive sodium-chloride cotransporter (NCC;SLC12A3) is central to sodium and blood pressure regulation. Metabolic syndrome induces NCC upregulation generating sodium-sensitive hypertension in experimental animal models. We tested the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ab5df2f6c83db8df2ff1e9cc1ba3a0
https://doi.org/10.1161/hypertensionaha.120.15933
https://doi.org/10.1161/hypertensionaha.120.15933
Publikováno v:
Kidney International. 88:1383-1391
A gastrointestinal-renal kaliuretic signaling axis has been proposed to regulate potassium excretion in response to acute potassium ingestion independent of the extracellular potassium concentration and aldosterone. Here we studied this presumed axis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3782ab3daf9eaeeef2294fc0ce58fe45
https://doi.org/10.1038/ki.2015.243
https://doi.org/10.1038/ki.2015.243
Autor:
Dyal C. Garg, Zhen Zhao, Richard A. Preston, Caroline Dudkowski, Alberto B. Alonso, Aziz Karim
Publikováno v:
Journal of Clinical Pharmacology
Azilsartan medoxomil (AZL‐M) is a potent angiotensin II receptor blocker that decreases blood pressure in a dose‐dependent manner. It is a prodrug that is not detected in blood after its oral administration because of its rapid hydrolysis to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf18e13ad326b6d9c1dcadf6d60b773
https://pubmed.ncbi.nlm.nih.gov/28750149
https://pubmed.ncbi.nlm.nih.gov/28750149
Autor:
Adel H. Karara, Vladimir Hanes, Hartmut Blode, Rose Silang, Richard A. Preston, Nagaraju Poola, Alberto B. Alonso, Pingping Ni
Publikováno v:
The Journal of Clinical Pharmacology. 47:1292-1302
The effects of combination hormone therapy of drospirenone (DRSP), a novel progestin with antialdosterone properties, and 17beta-estradiol (E2) on hydrochlorothiazide (HCTZ) pharmacokinetics/pharmacodynamics versus placebo were investigated in a doub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0805bf390298f61b0e48c3bddfafdc86
https://doi.org/10.1177/0091270007306560
https://doi.org/10.1177/0091270007306560
Autor:
Richard A. Preston, Paul M. Norris, Pingping Ni, Alberto B. Alonso, Adel H. Karara, Vladimir Hanes
Publikováno v:
Menopause. 14:408-414
Objective: Drospirenone (DRSP), a spironolactone analog with aldosterone antagonist activity, is a novel progestogen developed for use as hormone therapy in postmenopausal women in combination with 17A-estradiol (E2). DRSP/E2 lowers blood pressure wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d0b04b8888b78c238b8a2809c439c4
https://doi.org/10.1097/01.gme.0000243572.63322.f7
https://doi.org/10.1097/01.gme.0000243572.63322.f7
Publikováno v:
American Journal of Hypertension. 15:816-822
Background Aldosterone has been implicated in the pathogenesis of progressive cardiovascular disease. Drospirenone (DRSP) is a novel progestin with aldosterone receptor antagonist activity developed for hormone replacement therapy (HRT) as DRSP/17β-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02ca7e3bb6272e986ad908060e2373f0
https://doi.org/10.1016/s0895-7061(02)02980-1
https://doi.org/10.1016/s0895-7061(02)02980-1
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 64(2)
Several consistent lines of evidence indicate an association between sodium sensitivity and impaired nitric oxide bioactivity. Nevertheless, whether restoring nitric oxide in humans by pharmacological means can ameliorate sodium sensitivity has not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beed92526d521b9311d561e710e6f7d8
https://pubmed.ncbi.nlm.nih.gov/24842917
https://pubmed.ncbi.nlm.nih.gov/24842917
Autor:
Richard A. Preston, Alberto B. Alonso, Leonard R. Forte, David Afshartous, Rolando Rodco, Dyal C. Garg, Leopoldo Raij
Publikováno v:
Kidney international. 82(12)
A gastrointestinal–renal natriuretic signaling axis has been proposed to regulate sodium excretion in response to acute sodium ingestion. Such an axis is thought to be regulated by a gastrointestinal sodium sensor coupled to the activation/release
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185cb1d5d342ee5b00403418beefb1b9
https://pubmed.ncbi.nlm.nih.gov/23203021
https://pubmed.ncbi.nlm.nih.gov/23203021
Autor:
David Afshartous, Richard A. Preston, Rolando Rodriguez, Alberto B. Alonso, Sergio Medrano, Dyal C. Garg
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 53(5)
The combination of an aldosterone receptor antagonist added to an angiotensin-converting enzyme inhibitor has been demonstrated to reduce cardiovascular and renal end points in hypertensive humans but can produce hyperkalemia in the common clinical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beda5296b2d156e32e6c6f34aa2fc2db
https://pubmed.ncbi.nlm.nih.gov/19307465
https://pubmed.ncbi.nlm.nih.gov/19307465